Recent articles GlaxoSmithKline PLC

GSK: on the mend?

Glaxo’s chief executive has stepped down after nine years at the top. Has he left the pharma giant in good health? Alex Rankine reports.

A golden hello that says big companies aren’t hearing us

When it comes to ridiculous executive pay, GlaxoSmithKline still doesn’t get it, says Merryn Somerset Webb. But they’re not the only ones.

Glaxo faces China bribery claims

The Chinese government has accused pharma giant GlaxoSmithKline of paying $489m in bribes to doctors and lawyers in order to boost sales and profits.

Showing page 1 of 3
GlaxoSmithKline PLC overview

 

Don’t wait until March
Take back control of your investments NOW
Try 6 free issues then pay only £2.45 per issue
(normally £4.25)
Turn a no deal into a profitable one
SUBSCRIBE TO MONEYWEEK NOW